Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD.
Amoxicillin
/ therapeutic use
Anti-Bacterial Agents
/ therapeutic use
Bismuth
/ therapeutic use
Clarithromycin
/ therapeutic use
Drug Therapy, Combination
Gastroenterologists
Gastroenterology
Helicobacter Infections
/ diagnosis
Helicobacter pylori
Humans
Proton Pump Inhibitors
/ therapeutic use
Surveys and Questionnaires
Helicobacter pylori
diagnosis
gastroenterologists
gastroenterology fellows
guidelines
treatment
Journal
Helicobacter
ISSN: 1523-5378
Titre abrégé: Helicobacter
Pays: England
ID NLM: 9605411
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
revised:
18
09
2021
received:
01
09
2021
accepted:
23
09
2021
pubmed:
13
11
2021
medline:
1
2
2022
entrez:
12
11
2021
Statut:
ppublish
Résumé
Information on the management of Helicobacter (H.) pylori infection by gastroenterologists and gastroenterology fellows are scarce. We aimed to assess practice of gastroenterologists and gastroenterology fellows and their adherence to guidelines for diagnosis and treatment of H. pylori infection in Italy. All gastroenterologists and gastroenterology fellows attending the National Congress of Digestive Diseases - FISMAD were invited to fill-in an on-line questionnaire. The questionnaire included questions on the diagnosis and treatment of H. pylori infection. A total of 279 gastroenterologists and 61 gastroenterology fellows participated to the study. The Practices of gastroenterologists and gastroenterology fellows are in line with guidelines' recommendations, apart for the first-line treatment of H. pylori infection. Targeted educational interventions to improve adherence to guidelines are needed.
Sections du résumé
BACKGROUND
BACKGROUND
Information on the management of Helicobacter (H.) pylori infection by gastroenterologists and gastroenterology fellows are scarce. We aimed to assess practice of gastroenterologists and gastroenterology fellows and their adherence to guidelines for diagnosis and treatment of H. pylori infection in Italy.
MATERIALS AND METHODS
METHODS
All gastroenterologists and gastroenterology fellows attending the National Congress of Digestive Diseases - FISMAD were invited to fill-in an on-line questionnaire. The questionnaire included questions on the diagnosis and treatment of H. pylori infection.
RESULTS
RESULTS
A total of 279 gastroenterologists and 61 gastroenterology fellows participated to the study. The
CONCLUSIONS
CONCLUSIONS
Practices of gastroenterologists and gastroenterology fellows are in line with guidelines' recommendations, apart for the first-line treatment of H. pylori infection. Targeted educational interventions to improve adherence to guidelines are needed.
Identifiants
pubmed: 34766392
doi: 10.1111/hel.12862
pmc: PMC9286052
doi:
Substances chimiques
Anti-Bacterial Agents
0
Proton Pump Inhibitors
0
Amoxicillin
804826J2HU
Clarithromycin
H1250JIK0A
Bismuth
U015TT5I8H
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12862Informations de copyright
© 2021 The Authors. Helicobacter published by John Wiley & Sons Ltd.
Références
Gastroenterology. 2016 Jul;151(1):51-69.e14
pubmed: 27102658
Gut. 2021 Jan;70(1):1-2
pubmed: 32958543
Am J Gastroenterol. 2017 Feb;112(2):212-239
pubmed: 28071659
World J Gastroenterol. 2018 Jul 21;24(27):3021-3029
pubmed: 30038469
Helicobacter. 2019 Sep;24 Suppl 1:e12637
pubmed: 31486237
Dig Dis. 2019;37(6):434-443
pubmed: 31067529
J Gastroenterol Hepatol. 2020 Sep;35(9):1495-1502
pubmed: 32181516
Aliment Pharmacol Ther. 2018 May;47(9):1261-1269
pubmed: 29536561
Clin Gastroenterol Hepatol. 2003 Jul;1(4):273-8
pubmed: 15017668
Helicobacter. 2019 Dec;24(6):e12656
pubmed: 31571330
Eur J Gastroenterol Hepatol. 2018 Jun;30(6):621-625
pubmed: 29481383
Dig Liver Dis. 2015 Nov;47(11):903-12
pubmed: 26253555
Aliment Pharmacol Ther. 2016 Feb;43(4):514-33
pubmed: 26694080
Helicobacter. 2021 Apr;26(2):e12780
pubmed: 33596342
Gut. 2021 Jan;70(1):40-54
pubmed: 32958544
Rev Gastroenterol Peru. 2015 Oct-Dec;35(4):295-305
pubmed: 26802882
Helicobacter. 2022 Feb;27(1):e12862
pubmed: 34766392
Gastroenterology. 2018 Nov;155(5):1372-1382.e17
pubmed: 29990487
Ann Gastroenterol. 2019 Jan-Feb;32(1):52-59
pubmed: 30598592
World J Gastroenterol. 2018 Aug 7;24(29):3204-3221
pubmed: 30090002
Helicobacter. 2019 Aug;24(4):e12593
pubmed: 31111627
Eur J Clin Invest. 2018 Jan;48(1):
pubmed: 29144559
Eur J Intern Med. 2016 Jul;32:84-90
pubmed: 27134145
Eur J Clin Pharmacol. 2018 Jan;74(1):1-13
pubmed: 28990120
Cochrane Database Syst Rev. 2016 Jun 28;(6):CD009034
pubmed: 27351542
Antibiotics (Basel). 2021 Feb 21;10(2):
pubmed: 33669969
Gut. 2017 Jan;66(1):6-30
pubmed: 27707777
Am J Gastroenterol. 2019 Jun;114(6):900-906
pubmed: 31095531
Gastroenterology. 2017 Aug;153(2):420-429
pubmed: 28456631
Gastroenterology. 2019 Jul;157(1):44-53
pubmed: 30998990
Aliment Pharmacol Ther. 2012 May;35(10):1221-30
pubmed: 22469191
Scand J Gastroenterol. 2018 Jun;53(6):661-664
pubmed: 29688095
J Gastroenterol Hepatol. 2021 Oct;36(10):2649-2658
pubmed: 34114673
Helicobacter. 2021 Apr;26(2):e12775
pubmed: 33368852
Microb Drug Resist. 2020 Aug;26(8):909-917
pubmed: 32101078
Cochrane Database Syst Rev. 2013 Dec 11;(12):CD008337
pubmed: 24338763
Gut. 2015 Sep;64(9):1353-67
pubmed: 26187502
Helicobacter. 2018 Aug;23(4):e12502
pubmed: 29924430
Lancet. 1993 Nov 27;342(8883):1317-22
pubmed: 7901634